Azor and Phlebitis - a phase IV clinical study of FDA data

Summary:

Phlebitis is reported as a side effect among people who take Azor (amlodipine besylate; olmesartan medoxomil), especially for people who are male, 50-59 old, also take Prednisone, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Phlebitis when taking Azor. It is created by eHealthMe based on reports of 3,584 people who have side effects when taking Azor from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Phlebitis?

Phlebitis (inflammation of the walls of a vein) is found to be associated with 1,510 drugs and 1,245 conditions by eHealthMe. Check the latest studies of Phlebitis.

On Oct, 21, 2025

3,584 people reported to have side effects when taking Azor.
Among them, 18 people (0.5%) have Phlebitis.

Among these 18 people:

What is the gender of people who have Phlebitis when taking Azor? *

female: 5.56 %
male: 94.44 %

What is the age of people who have Phlebitis when taking Azor? *

What are other drugs people take besides Azor? *

What are other side effects people have besides Phlebitis? *

Pneumonia: 18 people, 100.00%
Atherosclerosis (disorder of the arteries): 18 people, 100.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 18 people, 100.00%
Dyspnea (difficult or laboured breathing): 18 people, 100.00%
Wheezing (a high-pitched whistling sound made while you breath): 17 people, 94.44%
Hypotension (abnormally low blood pressure): 17 people, 94.44%
General Physical Health Deterioration (weak health status): 17 people, 94.44%
Hydrocele: 17 people, 94.44%
Hypoaesthesia (reduced sense of touch or sensation): 17 people, 94.44%
Hypophagia (reduced food intake): 17 people, 94.44%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 17 people, 94.44%
Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 5.56%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.56%
Asthma: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and have Phlebitis?

- Check whether Phlebitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azor:

Azor (3,922 reports)

Phlebitis treatments and more:

Phlebitis (13,501 reports)

How severe was Phlebitis and when was it recovered:

Phlebitis in Azor

Expand to all the drugs that have ingredients of amlodipine besylate; olmesartan medoxomil:

Phlebitis and drugs with ingredients of amlodipine besylate; olmesartan medoxomil (19 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Phlebitis:

Phlebitis (1,510 drugs)

Browse all the conditions that are associated with Phlebitis:

Phlebitis (1,245 conditions)

Drugs similar to Azor and Phlebitis :

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil (the active ingredients of Azor) and Azor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.